- Home
- BG vs RPRX Comparison
BG vs RPRX Comparison
Compare BG & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BG
- RPRX
- Stock Information
- Founded
- BG 1818
- RPRX 1996
- Country
- BG United States
- RPRX United States
- Employees
- BG N/A
- RPRX N/A
- Industry
- BG Packaged Foods
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BG Consumer Staples
- RPRX Health Care
- Exchange
- BG Nasdaq
- RPRX Nasdaq
- Market Cap
- BG 12.2B
- RPRX 14.0B
- IPO Year
- BG N/A
- RPRX 2020
- Fundamental
- Price
- BG $73.08
- RPRX $33.42
- Analyst Decision
- BG Buy
- RPRX Strong Buy
- Analyst Count
- BG 5
- RPRX 6
- Target Price
- BG $97.20
- RPRX $41.67
- AVG Volume (30 Days)
- BG 1.8M
- RPRX 4.7M
- Earning Date
- BG 02-05-2025
- RPRX 02-11-2025
- Dividend Yield
- BG 3.72%
- RPRX 2.63%
- EPS Growth
- BG N/A
- RPRX N/A
- EPS
- BG 7.99
- RPRX 1.91
- Revenue
- BG $53,108,000,000.00
- RPRX $2,263,576,000.00
- Revenue This Year
- BG $9.79
- RPRX $29.18
- Revenue Next Year
- BG $8.03
- RPRX $9.99
- P/E Ratio
- BG $9.14
- RPRX $17.48
- Revenue Growth
- BG N/A
- RPRX N/A
- 52 Week Low
- BG $67.40
- RPRX $24.05
- 52 Week High
- BG $114.92
- RPRX $33.69
- Technical
- Relative Strength Index (RSI)
- BG 47.29
- RPRX 78.16
- Support Level
- BG $69.44
- RPRX $32.28
- Resistance Level
- BG $71.59
- RPRX $33.69
- Average True Range (ATR)
- BG 2.07
- RPRX 0.69
- MACD
- BG 0.34
- RPRX -0.02
- Stochastic Oscillator
- BG 67.78
- RPRX 89.85
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes, and corn-based products in North and South America.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.